Home > News > Fast Pitch: Nanophase Technologies
April 3rd, 2007
Fast Pitch: Nanophase Technologies
Abstract:
Nanophase Technologies (Nasdaq: NANX) likes to say it is "transforming the boundaries of performance ... today," and that phrase seems to fit this interesting small cap.
The company is a leading developer and commercial manufacturer of nanomaterials. It produces these products for a variety of diverse markets: personal care, sunscreen, abrasion-resistant applications, environmental catalysts, antimicrobial products, and a variety of ultra-fine polishing applications, including semiconductor wafers, hard disk drives, and optics.
Nanophase has two distinct and patented processes for the preparation and commercial manufacturing of nanopowder metal oxides. It has developed a process, Discrete Particle Encapsulation, to coat the surface of its nanoparticles with a thin polymeric shell that enables compatibility of the particles with a wide variety of fluids, resins, and polymers. Its products are available as nanoparticles, surface-treated nanoparticles, and stable nanoparticle dispersions in aqueous or organic media, providing customers with nanomaterials in readily usable forms.
Source:
fool.com
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||